Phospholipids in Human Atherosclerosis

  • P. Avogaro
  • G. Bittolo Bon
  • G. Cazzolato
Conference paper
Part of the Proceedings in Life Sciences book series (LIFE SCIENCES)


Despite their relevant physiological and structural role, phospholipids (PL) have not gained favour in clinical assessment of human atherosclerosis. Already in 1951, Gertler et al. recorded higher values of serum lipid phosphorus in coronary patients than in controls. Furthermore, it was shown that the serum cholesterol/lipid phosphorus is increased in the presence of coronary heart disease (CHD). The same authors suggested a “chemotype” which included the analysis of serum cholesterol, phospholipids and uric acid. A recommandation was also given to increase the values of plasma PL, thus reestablishing a normal C/PL ratio. The meaning of the recorded variations of PL plasma values has not been discussed. An increased C/PL ratio has also been recorded in type II hyperlipoproteinaemia (Peeters 1976). Increased values of ratio sphyngomye-lin/phosphatidylcholine (SM/PC) was observed in types II and IIB, being normal in type IV (Peeters 1976). The lecithin/sphyngomyelin ratio is abnormally low in homozygotes with familial xanthomatosis hypercholesterolaemia (FXH) (Mills et al. 1976). In the low density lipoproteins (LDL) of FXH, an increased C/PL ratio was recorded with a decreased lecithin/sphyngomyelin ratio (Jadhav and Thompson 1979). Since this abnormal composition of LD1 normalizes following plasma exchange it has been suggested that the abnormal composition of LDL in FHX is due to hypocatabolism and then to the aging of LDL (Jashav and Thompson 1979). The chemical percentage composition of the major lipoprotein classes has been studied in survivors of myocardial infarction (Avogaro et al. 1979).


Recorded Variation Human Atherosclerosis Lower Molecular Weight Band Abnormal Composition Drug Affecting Lipid Metabolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Avogaro P (1983) Phospholipids and atherosclerosis. In: Avogaro P, Mancini M, Ricci G, Paoletti R (eds) Phospholipids and atherosclerosis. Raven, New York, pp 211–214Google Scholar
  2. Avogaro P, Cazzolato G, Bittolo Bon G, Belussi F (1979) Levels and chemical composition of HDL HDL and other major lipoprotein classes in survivors of myocardial infarction. Artery 5:495–508Google Scholar
  3. Gertler MM, Garn SM, White PD (1951) Young candidates for coronary heart disease. JAMA 147: 621–624Google Scholar
  4. Goldstein JL, Ho YK, Basu SK, Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76:333–377PubMedCrossRefGoogle Scholar
  5. Henriksen T, Mahoney E, Steinberg D (1981) Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci USA 78:6499–6503PubMedCrossRefGoogle Scholar
  6. Jadhav AV, Thompson GR (1979) Reversible abnormalities of low density lipoprotein composition in familial hypercholesterolaemia. Eur J Clin Invest 9:63–67PubMedCrossRefGoogle Scholar
  7. Mills GL, Taylaur CE, Chapman MJ (1976) Low density lipoproteins in patients homozygous for familial hyperbetalipoproteinaemia. Clin Sci Mol Med 51:221–231PubMedGoogle Scholar
  8. Parthasarathy S, Steinbrecher VP, Barnett J, Witzum JL, Steinberg D (1985) Essential role of phos-pholipase A2 activity in endothelial cell induced modification of low density lipoprotein. Proc Natl Acad Sci USA 82:3000–3004PubMedCrossRefGoogle Scholar
  9. Peeters H (1976) The biological significance of the plasma phospholipids. In: Peeters H (ed) Phosphatidylcholine. Springer, Berlin Heidelberg New York, pp 10Google Scholar
  10. Sevanian A, Kim E (1985) Phospholipase A2 dependent release of fatty acids from peroxidized membranes. J Free Rad Biol Med 1:263–271CrossRefGoogle Scholar
  11. Smith DL, Willis AL, Mahmud I (1984) Eicosanoid effects on cell proliferation in vitro: relevance to atherosclerosis. Prostagl Leukotrien Med 16:1–10CrossRefGoogle Scholar
  12. Steinbrecher UP, Parthasarathy S, Leake DS, Witzum JL, Steinberg D (1984) Modification of low density lipoproteins by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 81:3883–3887PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • P. Avogaro
  • G. Bittolo Bon
  • G. Cazzolato
    • 1
  1. 1.Unit for AtherosclerosisRegional General HospitalVeniceItaly

Personalised recommendations